Latest news from 23andMe on Newswise en-us Copyright 2024 Newswise 115 31 / /images/newswise-logo-rss.gif /articles/23andme-launches-new-genotyping-services-for-research/?sc=rsin /articles/23andme-launches-new-genotyping-services-for-research/?sc=rsin Wed, 13 Jul 2016 10:00:14 EST Today 23andMe announced the launch of its new Genotyping Services for Research (GSR) platform, providing scientists with an end-to-end service to incorporate genetic information into their studies. 23andMe /articles/new-effort-by-23andme-could-increase-diversity-in-genetic-research/?sc=rsin /articles/new-effort-by-23andme-could-increase-diversity-in-genetic-research/?sc=rsin Tue, 05 Apr 2016 11:00:29 EST 23andMe, Inc., the leading personal genetics company, today announced that the National Institutes of Health (NIH) has funded a promising new study by scientists at 23andMe that could help alleviate some of the existing disparities in genetic research between people of European ancestry and people of African, Latino and Asian ancestry. 23andMe /articles/23andme-enables-genetic-research-for-researchkit-apps/?sc=rsin /articles/23andme-enables-genetic-research-for-researchkit-apps/?sc=rsin Mon, 21 Mar 2016 14:05:01 EST 23andMe today announced a new ResearchKit module that allows researchers to seamlessly integrate genetic information into their app-based studies. ResearchKit, an open source software framework designed by Apple, makes it easy for researchers to create studies for iPhone. 23andMe /articles/is-being-a-morning-person-in-your-dna/?sc=rsin /articles/is-being-a-morning-person-in-your-dna/?sc=rsin Tue, 02 Feb 2016 11:00:39 EST 23andMe, Inc., the leading personal genetics company, today announced the results of one of the largest genome-wide association studies of its kind, identifying genetic variants associated with being a morning person. Published in Nature Communications the study identified 15 locations in DNA (loci) associated with "morningness." 23andMe /articles/23andme-genetic-service-now-fully-accessible-to-customers-in-new-york-and-maryland/?sc=rsin /articles/23andme-genetic-service-now-fully-accessible-to-customers-in-new-york-and-maryland/?sc=rsin Fri, 04 Dec 2015 09:00:00 EST 23andMe, Inc., the leading personal genetics company, today announced that its service is now completely available to people both in New York and Maryland. Previously, customers in New York could not ship saliva samples from the state, while state law in Maryland prohibited direct-to-consumer genetic testing all together. 23andMe /articles/23andme-launches-new-customer-experience-reports-include-carrier-status-that-meet-fda-standards-wellness-traits-and-ancestry/?sc=rsin /articles/23andme-launches-new-customer-experience-reports-include-carrier-status-that-meet-fda-standards-wellness-traits-and-ancestry/?sc=rsin Wed, 21 Oct 2015 00:05:00 EST 23andMe, Inc., the leading personal genetics company, today announced the launch of their new Personal Genome Service (PGS). Following two years of work with the FDA, extensive user comprehension testing and a complete redesign, 23andMe is launching an entirely new experience that includes carrier status, wellness, trait and ancestry reports. 23andMe /articles/23andme-raises-115-million-in-series-e-financing-led-by-fidelity-management-research-company/?sc=rsin /articles/23andme-raises-115-million-in-series-e-financing-led-by-fidelity-management-research-company/?sc=rsin Wed, 14 Oct 2015 08:00:00 EST 23andMe, Inc., the leading personal genetics company, today announced it has raised $115 million in a Series E financing led by Fidelity Management & Research Company. 23andMe /articles/veteran-genomics-and-biotech-executive-dean-schorno-cpa-joins-23andme-as-chief-financial-officer-and-head-of-operations/?sc=rsin /articles/veteran-genomics-and-biotech-executive-dean-schorno-cpa-joins-23andme-as-chief-financial-officer-and-head-of-operations/?sc=rsin Mon, 17 Aug 2015 09:00:00 EST 23andMe, Inc. today announced the appointment of Dean Schorno, CPA, as chief financial officer and head of operations for the company. In his new role, Schorno will oversee 23andMe's global financial and clinical laboratory operations. 23andMe /articles/23andme-genotypes-one-millionth-customer/?sc=rsin /articles/23andme-genotypes-one-millionth-customer/?sc=rsin Thu, 18 Jun 2015 09:00:00 EST 23andMe, Inc., the leading personal genetics company, today announced it has genotyped more than one million people worldwide. By accessing their own DNA to learn more about themselves, 23andMe customers have helped push genetic testing into the mainstream, and helped power a new genetic research model. 23andMe /articles/23andme-launches-the-lupus-research-study-in-collaboration-with-pfizer-inc/?sc=rsin /articles/23andme-launches-the-lupus-research-study-in-collaboration-with-pfizer-inc/?sc=rsin Tue, 05 May 2015 14:15:33 EST 23andMe, Inc., the leading personal genetics company, today announced the launch of the Lupus Research Study in collaboration with Pfizer Inc. The companies aim to enroll 5,000 individuals with systemic lupus erythematosus, more commonly known as lupus, into the study to help better understand the genetics of lupus. The effort is also in collaboration with the Lupus Research Institute, and in concert with Lupus Awareness Month in May. 23andMe /articles/bioinformatics-pioneer-robert-gentleman-ph-d-joins-23andme-leadership-team/?sc=rsin /articles/bioinformatics-pioneer-robert-gentleman-ph-d-joins-23andme-leadership-team/?sc=rsin Thu, 02 Apr 2015 09:00:00 EST Bioinformatics Pioneer Robert Gentleman, Ph.D., Joins 23andMe Leadership Team 23andMe /articles/23andme-appoints-board-certified-genetic-counselor-erynn-gordon-to-23andme-s-management-team/?sc=rsin /articles/23andme-appoints-board-certified-genetic-counselor-erynn-gordon-to-23andme-s-management-team/?sc=rsin Thu, 19 Mar 2015 12:00:00 EST 23andMe, the leading personal genetics company, today announced the appointment of Erynn Gordon, MS, CGC as medical marketing director. 23andMe /articles/23andme-to-create-therapeutics-group-appoints-scientific-luminary-r-d-executive-richard-scheller-ph-d-to-lead/?sc=rsin /articles/23andme-to-create-therapeutics-group-appoints-scientific-luminary-r-d-executive-richard-scheller-ph-d-to-lead/?sc=rsin Thu, 12 Mar 2015 08:00:00 EST 23andMe today announced the creation of a new therapeutics group and appointment of Richard Scheller, Ph.D. as chief science officer and head of therapeutics to lead it. Dr. Scheller retired in December 2014 from a distinguished 14 year career as an executive at Genentech where he was the executive vice president of research and early development. 23andMe /articles/researchers-from-stanford-university-and-23andme-discover-genetic-links-to-rosacea/?sc=rsin /articles/researchers-from-stanford-university-and-23andme-discover-genetic-links-to-rosacea/?sc=rsin Tue, 10 Mar 2015 14:05:00 EST Today marked the publication of the first ever genome-wide association study of rosacea, a common and incurable skin disorder. Led by Dr. Anne Lynn S. Chang of Stanford University's School of Medicine, and co-authored by 23andMe, the study is the first to identify genetic factors for this condition. 23andMe /articles/23andme-appoints-kate-black-as-privacy-officer-and-corporate-counsel/?sc=rsin /articles/23andme-appoints-kate-black-as-privacy-officer-and-corporate-counsel/?sc=rsin Thu, 26 Feb 2015 15:05:00 EST 23andMe, the leading personal genetics company, today announced the appointment of Kate Black as Privacy Officer and Corporate Counsel. Black brings a strong background in international, federal, and state privacy laws as well as health care regulations. As a member of the legal and regulatory team, she will be responsible for reviewing, updating and enhancing the company's privacy and consent policies for customers in the U.S. and abroad. She joined the company January 5, 2015 and reports to Kathy Hibbs, chief legal and regulatory affairs officer. 23andMe /articles/23andme-granted-authorization-by-fda-to-market-first-direct-to-consumer-genetic-test-under-regulatory-pathway-for-novel-devices/?sc=rsin /articles/23andme-granted-authorization-by-fda-to-market-first-direct-to-consumer-genetic-test-under-regulatory-pathway-for-novel-devices/?sc=rsin Thu, 19 Feb 2015 17:30:00 EST 23andMe has been granted authority by the U.S. Food and Drug Administration (FDA) to market the first direct-to-consumer genetic test under a regulatory classification for novel devices. 23andMe /articles/23andme-study-uncovers-the-genetics-of-motion-sickness/?sc=rsin /articles/23andme-study-uncovers-the-genetics-of-motion-sickness/?sc=rsin Tue, 03 Feb 2015 09:00:00 EST Data by 23andMe links motion sickness to 35 genetic variants. 23andMe /articles/23andme-announces-collaboration-with-pfizer-inc-to-conduct-genetic-research-through-23andme-s-research-platform/?sc=rsin /articles/23andme-announces-collaboration-with-pfizer-inc-to-conduct-genetic-research-through-23andme-s-research-platform/?sc=rsin Mon, 12 Jan 2015 09:00:00 EST 23andMe and Pfizer collaborate to establish new lupus research community. 23andMe /articles/23andme-and-genentech-to-analyze-genomic-data-for-parkinson-s-disease/?sc=rsin /articles/23andme-and-genentech-to-analyze-genomic-data-for-parkinson-s-disease/?sc=rsin Tue, 06 Jan 2015 10:00:00 EST 23andMe and Genentech are partnering to analyze the genetic patterns associated with Parkinson's Disease. 23andMe /articles/23andme-announces-agreement-with-pfizer-inc-to-research-genetics-of-ulcerative-colitis-and-crohn-s-disease/?sc=rsin /articles/23andme-announces-agreement-with-pfizer-inc-to-research-genetics-of-ulcerative-colitis-and-crohn-s-disease/?sc=rsin Tue, 12 Aug 2014 09:00:00 EST 23andMe and Pfizer Inc. announce a new research collaboration to study Inflammatory Bowel Disease (IBD) in a nationwide initiative designed to recruit and genotype individuals who have Crohn's disease or ulcerative colitis. 23andMe